journal
Journals Journal of Cancer Research and...

Journal of Cancer Research and Clinical Oncology

https://read.qxmd.com/read/39259360/the-risk-of-endocrine-interventions-in-carriers-of-a-genetic-predisposition-for-breast-and-gynecologic-cancers-recommendations-of-the-german-consortium-for-hereditary-breast-and-ovarian-cancer
#1
REVIEW
O Ortmann, S Schüler-Toprak, K Kast
PURPOSE: To support doctors in counselling women with genetic predisposition for breast or gynecologic cancers on endocrine interventions. METHODS: Evidence on the safety of endocrine interventions for fertility treatment, contraception, hormone replacement therapy after risk-reducing salpingo-oophorectomy (RRSO) or treatment of symptoms during peri- and postmenopause was analysed for carriers of probably pathogenic and pathogenic variants in BRCA1 or BRCA2 (BRCA1/2-pV), in other breast and ovarian cancer genes and the Lynch Syndrome...
September 11, 2024: Journal of Cancer Research and Clinical Oncology
https://read.qxmd.com/read/39249593/apalutamide-for-non-metastatic-castration-resistant-prostate-cancer-nmcrpc-real-world-data-of-a-multicenter-study
#2
MULTICENTER STUDY
Axel Hegele, Rainer Häußermann, Stefan Schultheis, Lennart Skrobek, Meike Vink, Sebastian Hollwegs, Martin Ludwig, Petra Huwe, Manfred Maywurm, Anke Bartsch-Polle, Jost Weber, Markus Thiemer, Denny Varughese
PURPOSE: Apalutamide plus androgen-deprivation therapy (ADT) improved outcomes in patients with non-metastatic castration-resistant prostate cancer (nmCRPC). Nevertheless real-world data are limited. The aim of this multicenter study was to generate real-world data from nmCRPC patients treated with ADT plus apalutamide. METHODS: In this observational cohort based investigator initiated trial data of nmCRPC patients receiving apalutamide plus ADT were collected focusing on patient demographic data, prostate-specific antigen (PSA) declines, safety profile including dose modification/discontinuation as well as subsequent therapy and metastasis-free survival (MFS)...
September 9, 2024: Journal of Cancer Research and Clinical Oncology
https://read.qxmd.com/read/39249584/integrative-radiopathomics-model-for-predicting-progression-free-survival-in-patients-with-nonmetastatic-nasopharyngeal-carcinoma
#3
JOURNAL ARTICLE
Jing Hou, Xiaochun Yi, Handong Li, Qiang Lu, Huashan Lin, Junjun Li, Biao Zeng, Xiaoping Yu
PURPOSE: To construct an integrative radiopathomics model for predicting progression-free survival (PFS) in nonmetastatic nasopharyngeal carcinoma (NPC) patients. METHODS: 357 NPC patients who underwent pretreatment MRI and pathological whole-slide imaging (WSI) were included in this study and randomly divided into two groups: a training set (n = 250) and validation set (n = 107). Radiomic features extracted from MRI were selected using the minimum redundancy maximum relevance and least absolute shrinkage and selection operator methods...
September 9, 2024: Journal of Cancer Research and Clinical Oncology
https://read.qxmd.com/read/39249161/paclitaxel-hyperthermia-suppresses-gastric-cancer-migration-through-mir-183-5p-ppp2ca-akt-gsk3%C3%AE-%C3%AE-catenin-axis
#4
JOURNAL ARTICLE
Xiansheng Yang, Chang Liu, Zheng Li, Juncai Wen, Jinfu He, Yunxin Lu, Quanxing Liao, Tian Wang, Hongsheng Tang, Xianzi Yang, Lisi Zeng
BACKGROUND: Gastric cancer (GC), a prevalent malignant tumor which is a leading cause of death from malignancy around the world. Peritoneal metastasis accounts for the major cause of mortality in patients with GC. Despite hyperthermia intraperitoneal chemotherapy (HIPEC) improves the therapeutic effect of GC, it's equivocal about the mechanism under HIPEC. METHODS: MiR-183-5p expression was sifted from miRNA chip and detected in both GC patients and cell lines by qRT-PCR...
September 9, 2024: Journal of Cancer Research and Clinical Oncology
https://read.qxmd.com/read/39244518/clinical-characteristics-of-kras-mutation-subtypes-in-non-small-cell-lung-cancer-population-in-xinjiang-china-and-their-impact-on-the-prognosis-of-immunotherapy
#5
JOURNAL ARTICLE
Guomin Gu, Chunling Liu, Xiaodan Zhu, Yan Yang, Shuming Song, Yan Zhao, Gang Sun
PURPOSE: Non-small cell lung cancer (NSCLC) is a highly fatal malignancy. The Kirsten rat sarcoma viral oncogene (KRAS) gene profoundly impacts patient prognosis. This study aims to explore the correlation between KRAS mutation subtypes, clinical data, and the impact of these subtypes on immunotherapy. MATERIALS AND METHODS: Tumor samples from 269 NSCLC patients at the Affiliated Cancer Hospital of Xinjiang Medical University were analyzed. Patients received first- or second-line therapy without targeted therapy...
September 7, 2024: Journal of Cancer Research and Clinical Oncology
https://read.qxmd.com/read/39237750/construction-of-a-clinical-prediction-model-for-the-diagnosis-of-immune-thrombocytopenia-based-on-clinical-laboratory-parameters
#6
JOURNAL ARTICLE
Kangying Zhong, Yuqing Pei, Ziyan Yang, Qin Zheng
PURPOSE: Primary immune thrombocytopenia (ITP) is an autoimmune bleeding disorder characterized by isolated thrombocytopenia that is often misdiagnosed due to the lack of a gold standard for diagnosis and currently relies on exclusionary approaches. This project combines several laboratory parameters to construct a clinical prediction model for adult ITP patients. METHODS: A total of 428 patients with thrombocytopenia who visited the West China Hospital of Sichuan University between January 2021 and March 2023 were enrolled...
September 6, 2024: Journal of Cancer Research and Clinical Oncology
https://read.qxmd.com/read/39237674/nr3c2-affects-the-proliferation-and-invasiveness-of-colon-cancer-cells-through-the-wnt-%C3%AE-catenin-signaling-pathway
#7
JOURNAL ARTICLE
Ke Nie, Zhong-Jiang He, Ling-Jun Kong
PURPOSE: The aim of this study was to explore the potential correlation between the nuclear receptor subfamily 3 group C member 2 (NR3C2) and outcomes of colon cancer, along with the mechanisms underlying this association. METHOD: mRNA (messenger RNA) data and clinical records pertaining to colon cancer were retrieved from The Cancer Genome Atlas (TCGA) database. The analysis of NR3C2 expression discrepancies between normal colon and tumor tissues was conducted using R software...
September 5, 2024: Journal of Cancer Research and Clinical Oncology
https://read.qxmd.com/read/39230684/operationalizing-urgency-in-oncology-ethical-challenges-amidst-the-pandemic
#8
LETTER
Aaron Lawson McLean
No abstract text is available yet for this article.
September 4, 2024: Journal of Cancer Research and Clinical Oncology
https://read.qxmd.com/read/39230677/the-role-of-local-ablative-therapy-in-patients-with-advanced-invasive-mucinous-adenocarcinoma-of-the-lung
#9
JOURNAL ARTICLE
Soo Han Kim, Hayoung Seong, Jonggeun Lee, Hyo Yeong Ahn, Jeong Su Cho, Hoseok I, Yeong Dae Kim, Min Ki Lee, Jung Seop Eom, Mi-Hyun Kim
PURPOSE: Invasive mucinous adenocarcinoma (IMA) of the lungs is a rare subtype of lung adenocarcinoma with a limited understanding of its prognosis, particularly in advanced stages. This study aimed to assess the prognosis of patients with advanced IMA by focusing on treatment modalities. METHODS: This single-center retrospective study evaluated 33 patients with IMAs diagnosed with advanced-stage disease or disease progression after curative treatment between 2011 and 2021...
September 4, 2024: Journal of Cancer Research and Clinical Oncology
https://read.qxmd.com/read/39222144/correction-to-psychosocial-factors-associated-with-quality-of-life-in-cancer-survivors-umbrella-review
#10
Viktorya Voskanyan, Chiara Marzorati, Diana Sala, Roberto Grasso, Ricardo Pietrobon, Iris van der Heide, Merel Engelaar, Nanne Bos, Augusto Caraceni, Norbert Couspel, Montse Ferrer, Mogens Groenvold, Stein Kaasa, Claudio Lombardo, Aude Sirven, Hugo Vachon, Galina Velikova, Cinzia Brunelli, Giovanni Apolone, Gabriella Pravettoni
No abstract text is available yet for this article.
September 2, 2024: Journal of Cancer Research and Clinical Oncology
https://read.qxmd.com/read/39212783/tumor-board-simulation-improves-interdisciplinary-decision-making-in-medical-students
#11
JOURNAL ARTICLE
Kevin Fink, Marie Forster, Matthias Oettle, Marcel Büttner, Chukwuka Eze, Lukas Käsmann, Amanda Tufman, Diego Kauffmann-Guerrero, Toki A Bolt, Julia Kovacs, Jens Neumann, Johannes Mücke, Sonja Heuser, Stefanie Corradini, Franziska Walter, Maximilian Niyazi, Claus Belka, Martin Dreyling, Martin R Fischer, Daniel F Fleischmann
INTRODUCTION: Training of interdisciplinary clinical reasoning and decision-making skills, essential in daily clinical practice in oncological specialties, are still underrepresented in medical education. Therefore, at LMU University Hospital Munich, we implemented a didactically modified tumor board simulation with experts from five different disciplines (medical oncology, pathology, radiation oncology, radiology, and surgery) presenting patient cases into a one-week course on the basic principles of oncology...
August 30, 2024: Journal of Cancer Research and Clinical Oncology
https://read.qxmd.com/read/39212774/nusap1-promotes-gastric-cancer-radioresistance-by-inhibiting-ubiquitination-of-anxa2-and-is-suppressed-by-mir-129-5p
#12
JOURNAL ARTICLE
Yugang Ge, Biao Wang, Jian Xiao, Hongshuai Wu, Qing Shao
BACKGROUND: Radiotherapy is an important strategy for the treatment of advanced gastric cancer (GC), while the radioresistance limits its effectiveness. Nucleolar and spindle associated protein 1 (NUSAP1) was implicated in cancer progression and chemoresistance. However, the underlying mechanisms of NUSAP1 influencing GC radioresistance remain largely unknown. METHODS: Meta-analysis was conducted to systematically evaluate the prognostic value of NUSAP1 in human cancers...
August 30, 2024: Journal of Cancer Research and Clinical Oncology
https://read.qxmd.com/read/39210153/effects-of-exosomes-and-inflammatory-response-on-tumor-a-bibliometrics-study-and-visualization-analysis-via-citespace-and-vosviewer
#13
JOURNAL ARTICLE
Miao Yu, Yaxuan Jin, Kaize Yuan, Bohao Liu, Na Zhu, Ke Zhang, Shuying Li, Zhihui Tai
BACKGROUND: Tumor is a new organism formed by abnormal hyperplasia of local tissue cells under the action of various tumorigenic factors. Inflammation plays a decisive role in inducing tumorigenesis, promoting tumor development, invasion and migration. More and more evidence indicate that exosomes are involved in regulating the formation of tumor microenvironment in the process of proinflammatory carcinogenesis, leading to the stimulation of anti-tumor immune response or systemic immunosuppression, and exosomes play a crucial role in the development of tumor...
August 30, 2024: Journal of Cancer Research and Clinical Oncology
https://read.qxmd.com/read/39207555/testosterone-therapy-as-a-novel-approach-to-the-management-of-cytopenias-in-myelodysplastic-neoplasms-a-review-of-literature-and-case-report
#14
REVIEW
John Yan, Bradley Rockwell, Divij Verma, Srabani Sahu, Mendel Goldfinger, Amit Verma
PURPOSE: To explore the potential of testosterone therapy in managing cytopenias in myelodysplastic neoplasm and investigate the link between hypogonadism and hematologic malignancies. METHODS: A case of a patient with intermediate-risk myelodysplastic neoplasm and hypogonadism treated with testosterone replacement therapy is presented. Testosterone, prostate specific antigen, and erythropoietin levels were checked prior to therapy initiation and 3 months after...
August 29, 2024: Journal of Cancer Research and Clinical Oncology
https://read.qxmd.com/read/39198311/her2-amplification-subtype-intrahepatic-cholangiocarcinoma-exhibits-high-mutation-burden-and-t-cell-exhaustion-microenvironment
#15
JOURNAL ARTICLE
Xiaohong Pu, Lin Li, Feng Xu, Ziyu Wang, Yao Fu, Hongyan Wu, Jun Ren, Jun Chen, Beicheng Sun
OBJECTIVE: This study aimed to establish a uniform standard for the interpretation of HER2 gene and protein statuses in intrahepatic cholangiocarcinoma (ICC). We also intended to explore the clinical pathological characteristics, molecular features, RNA expression and immune microenvironment of HER2-positive ICC. METHODS: We analyzed a cohort of 304 ICCs using immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH) to identify HER2 status. Comprehensive analyses of the clinicopathological, molecular genetic, and RNA expression characterizations of ICCs with varying HER2 statuses were performed using next-generation sequencing...
August 28, 2024: Journal of Cancer Research and Clinical Oncology
https://read.qxmd.com/read/39198302/sulindac-exhibits-anti-proliferative-and-anti-invasive-effects-in-uterine-serous-carcinoma-cells
#16
JOURNAL ARTICLE
Shuning Chen, Weimin Kong, Xiaochang Shen, Boer Deng, Jennifer Haag, Nikita Sinha, Catherine John, Wenchuan Sun, Chunxiao Zhou, Victoria L Bae-Jump
PURPOSE: Uterine serous carcinoma (USC) is a highly aggressive and frequently recurring subtype of endometrial cancer with limited treatment options for advanced or recurrent stages. Sulindac, a classic non-steroidal anti-inflammatory drug, has demonstrated anti-tumor activity in several pre-clinical tumor models. This study aims to evaluate the effect of sulindac on cell proliferation and invasion in USC cells. METHODS: Human USC cell lines ARK-1 and SPEC2 were treated with different concentrations of sulindac...
August 28, 2024: Journal of Cancer Research and Clinical Oncology
https://read.qxmd.com/read/39192027/application-of-electronic-nose-technology-in-the-diagnosis-of-gastrointestinal-diseases-a-review
#17
REVIEW
Tan-Tan Ma, Zhiyong Chang, Nan Zhang, Hong Xu
Electronic noses (eNoses) are electronic bionic olfactory systems that use sensor arrays to produce response patterns to different odors, thereby enabling the identification of various scents. Gastrointestinal diseases have a high incidence rate and occur in 9 out of 10 people in China. Gastrointestinal diseases are characterized by a long course of symptoms and are associated with treatment difficulties and recurrence. This review offers a comprehensive overview of volatile organic compounds, with a specific emphasis on those detected via the eNose system...
August 27, 2024: Journal of Cancer Research and Clinical Oncology
https://read.qxmd.com/read/39190192/clinicopathological-association-of-cd93-expression-in-gastric-adenocarcinoma
#18
JOURNAL ARTICLE
Yun Shen, Yahui Wu, Mengfei Hao, Minghan Fu, Kai Zhu, Panru Luo, Jinsheng Wang
AIMS: CD93 was recently identified as a promising therapeutic target for angiogenesis blockade in various tumors. Herein, we aimed to investigate the expression and clinicopathological significance of CD93 in gastric adenocarcinoma. METHODS: The gene expression of CD93 gastric adenocarcinoma was assessed using The Cancer Genome Atlas (TCGA) dataset. We then analyzed CD93 expression in 404 cases of gastric adenocarcinoma using immunohistochemistry. Clinicopathological associations and prognostic implications of CD93 expression were further investigated...
August 27, 2024: Journal of Cancer Research and Clinical Oncology
https://read.qxmd.com/read/39180680/epigenetic-profiling-of-prostate-cancer-reveals-potential-prognostic-signatures
#19
JOURNAL ARTICLE
Simon Bernatz, Ian G Reddin, Tim R Fenton, Thomas J Vogl, Peter J Wild, Jens Köllermann, Philipp Mandel, Mike Wenzel, Benedikt Hoeh, Scherwin Mahmoudi, Vitali Koch, Leon D Grünewald, Renate Hammerstingl, Claudia Döring, Patrick N Harter, Katharina J Weber
PURPOSE: While epigenetic profiling discovered biomarkers in several tumor entities, its application in prostate cancer is still limited. We explored DNA methylation-based deconvolution of benign and malignant prostate tissue for biomarker discovery and the potential of radiomics as a non-invasive surrogate. METHODS: We retrospectively included 30 patients (63 [58-79] years) with prostate cancer (PCa) who had a multiparametric MRI of the prostate before radical prostatectomy between 2014 and 2019...
August 24, 2024: Journal of Cancer Research and Clinical Oncology
https://read.qxmd.com/read/39180675/atezolizumab-and-bevacizumab-induced-encephalitis-in-a-patient-with-advanced-hepatocellular-carcinoma-a-case-report-and-literature-review
#20
REVIEW
Min Sagong, Keun Tae Kim, Byoung Kuk Jang
Treatment with atezolizumab and bevacizumab is the first-line therapy for unresectable hepatocellular carcinoma. Although immune checkpoint inhibitors are novel and effective treatments, they can induce immune-related adverse events. However, neurological immune-related adverse events have rarely been reported. We report the case of a man in his 40s with hepatocellular carcinoma who developed life-threatening encephalitis after atezolizumab plus bevacizumab was administered. The patient presented with fever, headache, altered mentality, and general epileptic seizures, ten days after administration...
August 24, 2024: Journal of Cancer Research and Clinical Oncology
journal
journal
27571
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.